IDXX · Earnings call · 2026Q2T · Full report
Capital Return Program
IDEXX LABORATORIES INC /DE · 2026-08-04 · Importance 23 · Surprise 24 · In source text
IDEXX continues to evaluate share buybacks against potential mergers, acquisitions, and in-licensing opportunities. Management said excess cash has primarily been returned through share repurchases because of its conviction in the company’s long-term business outlook. Buybacks were described as the preferred capital-return method so far, although the company continues to assess alternative uses of capital. The transcript section did not disclose a repurchase amount, authorization balance, or timing.
Key facts
- IDEXX allocated $332 million to share repurchases during the second quarter and $693 million year-to-date.
- Capital allocated to share repurchases supported approximately a 2% year-over-year reduction in diluted shares outstanding in Q2.
- We continue to view share buybacks as the best way we've leveraged excess cash to deliver capital back to shareholders going forward.
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | realized | — | IDEXX allocated $332 million to share repurchases during the second quarter and $693 million year-to-date. |
| cash | negative | realized | — | IDEXX allocated $332 million to share repurchases during the second quarter and $693 million year-to-date. |